Zebrafish as a pharmacological tool: the how, why and when

Area of Science:

• Comparative genomics
• Cardiovascular pharmacology
• Drug discovery and development

Background:

• Zebrafish offer a unique combination of vertebrate relevance and invertebrate scalability for biological research.
• Their small size and aquatic environment facilitate high-throughput screening and chemical absorption.
• These characteristics make them ideal models for studying human diseases and evaluating drug efficacy.

Purpose of the Study:

• To highlight the utility of zebrafish as a model organism in biomedical research.
• To demonstrate the application of zebrafish in drug discovery, specifically for assessing compound effects on cardiac function.

Main Methods:

• Cloning of the zebrafish human ether-a-go-go-related gene (HERG) to mirror human cardiac ion channels.
• Utilizing zebrafish to screen for compounds that affect the QT interval, a measure of cardiac repolarization.

Main Results:

• The zebrafish HERG gene exhibits high homology with its human counterpart, validating its use as a model.
• The system enables rapid identification of drugs that prolong the QT interval using minimal compound amounts (micrograms).

Conclusions:

• Zebrafish are a valuable and scalable model for human disease research and drug development.
• This model system significantly accelerates the process of identifying potential cardiotoxic compounds, improving drug safety evaluations.